Redéen Stefan, Petersson Fredrik, Kechagias Stergios, Mårdh Erik, Borch Kurt
Department of Clinical and Experimental Medicine, Faculty of Health Sciences, University Hospital, Linköping, Sweden.
Scand J Gastroenterol. 2010 May;45(5):540-9. doi: 10.3109/00365521003624151.
To describe and explore the natural history of Helicobacter pylori infection and chronic gastritis in terms of gastric mucosal atrophy and ulcer development over time in a population-based cohort.
A population-based cohort of 314 volunteers was re-screened (median follow-up interval of 8.4 years) with gastroduodenoscopy with biopsy, assessment of H. pylori status, analysis of pepsinogens, and monitoring of a nonsteroidal anti-inflammatory drug (NSAID) use and alcohol and smoking habits.
The incidence of duodenal or prepyloric ulcer was 0.45 per 100 person years and was associated with weekly NSAID use (odds ratios, OR 27.8), weekly alcohol consumption (OR 19.4) and smoking (OR 31.0), but not with H. pylori status. De novo infection with H. pylori was not observed, and the infection had disappeared in 11 of 113 subjects. Among subjects with chronic gastritis, the incidence of atrophy of the corpus mucosa was 1.4 per 100 person years. Atrophy development was related to age (OR 1.23) and to the severity of chronic inflammation in the corpus mucosa at baseline (OR 8.98). Substituting atrophy for subnormal S-pepsinogen I/S-pepsingen II gave similar results.
In this cohort, the minimum incidence of ulcer was 0.45 per 100 person years. Smoking, alcohol, and NSAIDs, but not H. pylori infection were significant risk factors. The incidence of atrophy of the corpus mucosa was 1.4 per 100 person years with a positive relation to age and to the degree of chronic inflammation at baseline. Atrophy was stationary in advanced stages.
在一项基于人群的队列研究中,描述并探讨幽门螺杆菌感染和慢性胃炎在胃黏膜萎缩及溃疡发生发展方面随时间变化的自然史。
对314名基于人群的志愿者队列进行重新筛查(中位随访间隔8.4年),采用胃镜检查及活检、评估幽门螺杆菌状态、分析胃蛋白酶原,并监测非甾体抗炎药(NSAID)使用情况以及饮酒和吸烟习惯。
十二指肠或幽门前溃疡的发病率为每100人年0.45例,与每周使用NSAID(比值比,OR 27.8)、每周饮酒(OR 19.4)和吸烟(OR 31.0)相关,但与幽门螺杆菌状态无关。未观察到幽门螺杆菌的新发感染,113名受试者中有11人感染已消失。在慢性胃炎患者中,胃体黏膜萎缩的发病率为每100人年1.4例。萎缩的发生与年龄(OR 1.23)以及基线时胃体黏膜慢性炎症的严重程度(OR 8.98)有关。用胃蛋白酶原I/胃蛋白酶原II低于正常水平替代萎缩得到了相似结果。
在该队列中,溃疡的最低发病率为每100人年0.45例。吸烟、饮酒和NSAIDs是显著的危险因素,而幽门螺杆菌感染不是。胃体黏膜萎缩的发病率为每100人年1.4例,与年龄及基线时慢性炎症程度呈正相关。萎缩在晚期处于静止状态。